- Sputnik International
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

US Speeds Up Ebola Vaccine Trials, Large-Scale Manufacture

© East News / AP Photo/Keystone,Jean-Christophe BottA nurse holds a dose of experimental vaccine
A nurse holds a dose of experimental vaccine - Sputnik International
Subscribe
US Department of Health and Human Services said two government contracts to pharmaceutical companies could help accelerate the development and large-scale manufacture of two US Ebola vaccines.

WASHINGTON, December 24 (Sputnik) – Two government contracts to pharmaceutical companies could help accelerate the development and large-scale manufacture of two US Ebola vaccines, the country's Department of Health and Human Services (DHHS) has announced.

"Contracts to speed further development of two promising Ebola vaccines…could pave the way for commercial scale production of millions of vaccine doses if clinical trials prove safety and efficacy," the DHHS said in a statement Tuesday.

Ebola Health Care Workers - Sputnik International
World
Number of Ebola Cases in West Africa Increases by 90 Over 24 Hours: WHO

Under the contracts, pharmaceutical giant GlaxoSmithKline will move from the current pilot phase of Ebola vaccine testing and scale up manufacturing ability to potentially produce millions of vaccines if clinical trials are successful.

"The manufacturing scale-up of any vaccine is a complex process and differs greatly from producing the small number of doses typically used for preclinical research or early stage clinical trials," the DHHS statement explained.

According to the department, if manufacturing is increased now, the time it will take GlaxoSmithKline to produce Ebola vaccines on a large scale could be reduced from three years to between nine and twelve months, if clinical trials are effective.

A second DHHS contract with BioProtection Systems will determine the lowest dose of an experimental vaccine required to create an immune response.

"Defining the lowest dose at which the vaccine works will enable the greatest number of people to be vaccinated," the DHHS explained.

According to DHHS, clinical trials of US Ebola vaccines on volunteers in West Africa could begin in early 2015.

Actors parade on a street after performing at Anono school, during an awareness campaign against Ebola in Abidjan September 25, 2014 - Sputnik International
Italian NGO Used Toxic Untested Ebola Drug on Patients in Sierra Leone

The current Ebola outbreak in West Africa started in Guinea at the end of last year and later spread to the neighbouring countries. Some Ebola cases have been reported outside of West Africa, including in the United States.

According to the latest figures from the World Health Organization (WHO) the death toll from the Ebola outbreak has reached 7,373.

Ebola is spread through direct contact with the bodily fluids of those infected. There is no officially-approved cure for the virus yet, but several countries, including Russia, have been working on developing Ebola vaccines.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала